Abbott Laboratories Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains

Dow Jones08-19 04:35

DJ Abbott Laboratories Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Abbott Laboratories $(ABT)$ rallied 2.09% to $112.68 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.69% to 7,691.76 and Dow Jones Industrial Average falling 0.22% to 53,343.40.

The stock's rise snapped a two-day losing streak.

Abbott Laboratories closed 18.04% short of its 52-week high of $137.49, which the company reached on September 22nd.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ rose 3.33% to $271.11, Pfizer Inc. $(PFE)$ rose 1.41% to $27.25, and Merck & Co. Inc. $(MRK)$ fell 0.59% to $135.17.

Trading volume (9.7 M) remained 2.5 million below its 50-day average volume of 12.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 18, 2026.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment